Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read moreThis Information Sheet was developed by Eating Disorders Neurodiversity Australia.
Read more